昊海生物科技：楼国梁已累计减持公司股份149.14万股

Core Viewpoint - The company announced a share reduction plan by a major shareholder, which involves the potential sale of up to 1.5 million shares, representing approximately 0.6432% of the total share capital [1] Group 1: Shareholder Reduction Plan - The shareholder, Mr. Lou Guoliang, plans to reduce his holdings through both centralized bidding and block trading methods within three months following the announcement [1] - The maximum number of shares to be reduced is 1.5 million, with the reduction price determined by the secondary market [1] - As of September 29, 2025, Mr. Lou has successfully reduced his holdings by 1.4914 million shares, which is about 0.6413% of the company's total share capital [1]